nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Cerebral infarction—Carmustine—malignant glioma	0.0384	0.0384	CcSEcCtD
Cefpodoxime—Lung infiltration—Carmustine—malignant glioma	0.0267	0.0267	CcSEcCtD
Cefpodoxime—Lymphopenia—Temozolomide—malignant glioma	0.0236	0.0236	CcSEcCtD
Cefpodoxime—Nephropathy toxic—Carmustine—malignant glioma	0.0218	0.0218	CcSEcCtD
Cefpodoxime—Cerebration impaired—Temozolomide—malignant glioma	0.0205	0.0205	CcSEcCtD
Cefpodoxime—Oral candidiasis—Carmustine—malignant glioma	0.0197	0.0197	CcSEcCtD
Cefpodoxime—Oral candidiasis—Temozolomide—malignant glioma	0.019	0.019	CcSEcCtD
Cefpodoxime—Tooth disorder—Temozolomide—malignant glioma	0.0186	0.0186	CcSEcCtD
Cefpodoxime—Digestion impaired—Temozolomide—malignant glioma	0.0181	0.0181	CcSEcCtD
Cefpodoxime—Cholestasis—Temozolomide—malignant glioma	0.0159	0.0159	CcSEcCtD
Cefpodoxime—Liver injury—Temozolomide—malignant glioma	0.0144	0.0144	CcSEcCtD
Cefpodoxime—Disturbance in attention—Temozolomide—malignant glioma	0.0139	0.0139	CcSEcCtD
Cefpodoxime—Leukocytosis—Carmustine—malignant glioma	0.0133	0.0133	CcSEcCtD
Cefpodoxime—Vaginal inflammation—Temozolomide—malignant glioma	0.0121	0.0121	CcSEcCtD
Cefpodoxime—Candida infection—Carmustine—malignant glioma	0.0119	0.0119	CcSEcCtD
Cefpodoxime—Skin exfoliation—Carmustine—malignant glioma	0.0119	0.0119	CcSEcCtD
Cefpodoxime—Candida infection—Temozolomide—malignant glioma	0.0115	0.0115	CcSEcCtD
Cefpodoxime—Skin exfoliation—Temozolomide—malignant glioma	0.0115	0.0115	CcSEcCtD
Cefpodoxime—Vaginal infection—Temozolomide—malignant glioma	0.0114	0.0114	CcSEcCtD
Cefpodoxime—Aplastic anaemia—Temozolomide—malignant glioma	0.0113	0.0113	CcSEcCtD
Cefpodoxime—Mental disability—Carmustine—malignant glioma	0.0108	0.0108	CcSEcCtD
Cefpodoxime—Mental disability—Temozolomide—malignant glioma	0.0105	0.0105	CcSEcCtD
Cefpodoxime—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00929	0.00929	CcSEcCtD
Cefpodoxime—Thirst—Temozolomide—malignant glioma	0.00921	0.00921	CcSEcCtD
Cefpodoxime—Hyponatraemia—Carmustine—malignant glioma	0.00911	0.00911	CcSEcCtD
Cefpodoxime—Face oedema—Carmustine—malignant glioma	0.00876	0.00876	CcSEcCtD
Cefpodoxime—Face oedema—Temozolomide—malignant glioma	0.00847	0.00847	CcSEcCtD
Cefpodoxime—Dehydration—Temozolomide—malignant glioma	0.00815	0.00815	CcSEcCtD
Cefpodoxime—Dry skin—Temozolomide—malignant glioma	0.00804	0.00804	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0079	0.0079	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0079	0.0079	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00773	0.00773	CcSEcCtD
Cefpodoxime—Abdominal distension—Temozolomide—malignant glioma	0.00763	0.00763	CcSEcCtD
Cefpodoxime—Pancytopenia—Carmustine—malignant glioma	0.00745	0.00745	CcSEcCtD
Cefpodoxime—Sweating increased—Temozolomide—malignant glioma	0.00738	0.00738	CcSEcCtD
Cefpodoxime—Neutropenia—Carmustine—malignant glioma	0.00733	0.00733	CcSEcCtD
Cefpodoxime—Bronchitis—Temozolomide—malignant glioma	0.00729	0.00729	CcSEcCtD
Cefpodoxime—Pancytopenia—Temozolomide—malignant glioma	0.0072	0.0072	CcSEcCtD
Cefpodoxime—Dysuria—Temozolomide—malignant glioma	0.00709	0.00709	CcSEcCtD
Cefpodoxime—Neutropenia—Temozolomide—malignant glioma	0.00709	0.00709	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Carmustine—malignant glioma	0.00707	0.00707	CcSEcCtD
Cefpodoxime—Pneumonia—Carmustine—malignant glioma	0.00703	0.00703	CcSEcCtD
Cefpodoxime—Pollakiuria—Temozolomide—malignant glioma	0.007	0.007	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Temozolomide—malignant glioma	0.00692	0.00692	CcSEcCtD
Cefpodoxime—Weight increased—Temozolomide—malignant glioma	0.0069	0.0069	CcSEcCtD
Cefpodoxime—Renal failure—Carmustine—malignant glioma	0.00687	0.00687	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Temozolomide—malignant glioma	0.00684	0.00684	CcSEcCtD
Cefpodoxime—Stomatitis—Carmustine—malignant glioma	0.00682	0.00682	CcSEcCtD
Cefpodoxime—Pneumonia—Temozolomide—malignant glioma	0.0068	0.0068	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0067	0.0067	CcSEcCtD
Cefpodoxime—Stomatitis—Temozolomide—malignant glioma	0.00659	0.00659	CcSEcCtD
Cefpodoxime—Sinusitis—Temozolomide—malignant glioma	0.00634	0.00634	CcSEcCtD
Cefpodoxime—Haemoglobin—Carmustine—malignant glioma	0.00631	0.00631	CcSEcCtD
Cefpodoxime—Haemorrhage—Carmustine—malignant glioma	0.00628	0.00628	CcSEcCtD
Cefpodoxime—Hallucination—Carmustine—malignant glioma	0.00625	0.00625	CcSEcCtD
Cefpodoxime—Oedema peripheral—Carmustine—malignant glioma	0.00618	0.00618	CcSEcCtD
Cefpodoxime—Haemoglobin—Temozolomide—malignant glioma	0.0061	0.0061	CcSEcCtD
Cefpodoxime—Haemorrhage—Temozolomide—malignant glioma	0.00607	0.00607	CcSEcCtD
Cefpodoxime—Hallucination—Temozolomide—malignant glioma	0.00604	0.00604	CcSEcCtD
Cefpodoxime—Oedema peripheral—Temozolomide—malignant glioma	0.00598	0.00598	CcSEcCtD
Cefpodoxime—Erythema multiforme—Temozolomide—malignant glioma	0.00574	0.00574	CcSEcCtD
Cefpodoxime—Tinnitus—Temozolomide—malignant glioma	0.00566	0.00566	CcSEcCtD
Cefpodoxime—Alopecia—Carmustine—malignant glioma	0.00555	0.00555	CcSEcCtD
Cefpodoxime—Chills—Temozolomide—malignant glioma	0.00544	0.00544	CcSEcCtD
Cefpodoxime—Alopecia—Temozolomide—malignant glioma	0.00536	0.00536	CcSEcCtD
Cefpodoxime—Back pain—Carmustine—malignant glioma	0.00529	0.00529	CcSEcCtD
Cefpodoxime—Dysgeusia—Temozolomide—malignant glioma	0.00517	0.00517	CcSEcCtD
Cefpodoxime—Tremor—Carmustine—malignant glioma	0.00512	0.00512	CcSEcCtD
Cefpodoxime—Back pain—Temozolomide—malignant glioma	0.00511	0.00511	CcSEcCtD
Cefpodoxime—Anaemia—Carmustine—malignant glioma	0.00505	0.00505	CcSEcCtD
Cefpodoxime—Agitation—Carmustine—malignant glioma	0.00502	0.00502	CcSEcCtD
Cefpodoxime—Tremor—Temozolomide—malignant glioma	0.00495	0.00495	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Temozolomide—malignant glioma	0.0049	0.0049	CcSEcCtD
Cefpodoxime—Leukopenia—Carmustine—malignant glioma	0.00489	0.00489	CcSEcCtD
Cefpodoxime—Anaemia—Temozolomide—malignant glioma	0.00488	0.00488	CcSEcCtD
Cefpodoxime—Agitation—Temozolomide—malignant glioma	0.00485	0.00485	CcSEcCtD
Cefpodoxime—Malaise—Temozolomide—malignant glioma	0.00476	0.00476	CcSEcCtD
Cefpodoxime—Vertigo—Temozolomide—malignant glioma	0.00474	0.00474	CcSEcCtD
Cefpodoxime—Convulsion—Carmustine—malignant glioma	0.00473	0.00473	CcSEcCtD
Cefpodoxime—Leukopenia—Temozolomide—malignant glioma	0.00473	0.00473	CcSEcCtD
Cefpodoxime—Hypertension—Carmustine—malignant glioma	0.00472	0.00472	CcSEcCtD
Cefpodoxime—Palpitations—Temozolomide—malignant glioma	0.00467	0.00467	CcSEcCtD
Cefpodoxime—Chest pain—Carmustine—malignant glioma	0.00465	0.00465	CcSEcCtD
Cefpodoxime—Myalgia—Carmustine—malignant glioma	0.00465	0.00465	CcSEcCtD
Cefpodoxime—Anxiety—Carmustine—malignant glioma	0.00464	0.00464	CcSEcCtD
Cefpodoxime—Cough—Temozolomide—malignant glioma	0.00461	0.00461	CcSEcCtD
Cefpodoxime—Convulsion—Temozolomide—malignant glioma	0.00458	0.00458	CcSEcCtD
Cefpodoxime—Hypertension—Temozolomide—malignant glioma	0.00456	0.00456	CcSEcCtD
Cefpodoxime—Confusional state—Carmustine—malignant glioma	0.0045	0.0045	CcSEcCtD
Cefpodoxime—Myalgia—Temozolomide—malignant glioma	0.0045	0.0045	CcSEcCtD
Cefpodoxime—Anxiety—Temozolomide—malignant glioma	0.00448	0.00448	CcSEcCtD
Cefpodoxime—Discomfort—Temozolomide—malignant glioma	0.00444	0.00444	CcSEcCtD
Cefpodoxime—Dry mouth—Temozolomide—malignant glioma	0.0044	0.0044	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Carmustine—malignant glioma	0.00437	0.00437	CcSEcCtD
Cefpodoxime—Confusional state—Temozolomide—malignant glioma	0.00435	0.00435	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Temozolomide—malignant glioma	0.00431	0.00431	CcSEcCtD
Cefpodoxime—Anorexia—Carmustine—malignant glioma	0.00425	0.00425	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Temozolomide—malignant glioma	0.00422	0.00422	CcSEcCtD
Cefpodoxime—Hypotension—Carmustine—malignant glioma	0.00417	0.00417	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Temozolomide—malignant glioma	0.00417	0.00417	CcSEcCtD
Cefpodoxime—Anorexia—Temozolomide—malignant glioma	0.00411	0.00411	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00406	0.00406	CcSEcCtD
Cefpodoxime—Insomnia—Carmustine—malignant glioma	0.00403	0.00403	CcSEcCtD
Cefpodoxime—Paraesthesia—Carmustine—malignant glioma	0.004	0.004	CcSEcCtD
Cefpodoxime—Dyspnoea—Carmustine—malignant glioma	0.00398	0.00398	CcSEcCtD
Cefpodoxime—Somnolence—Carmustine—malignant glioma	0.00396	0.00396	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00393	0.00393	CcSEcCtD
Cefpodoxime—Insomnia—Temozolomide—malignant glioma	0.0039	0.0039	CcSEcCtD
Cefpodoxime—Decreased appetite—Carmustine—malignant glioma	0.00388	0.00388	CcSEcCtD
Cefpodoxime—Paraesthesia—Temozolomide—malignant glioma	0.00387	0.00387	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Carmustine—malignant glioma	0.00385	0.00385	CcSEcCtD
Cefpodoxime—Dyspnoea—Temozolomide—malignant glioma	0.00384	0.00384	CcSEcCtD
Cefpodoxime—Somnolence—Temozolomide—malignant glioma	0.00383	0.00383	CcSEcCtD
Cefpodoxime—Pain—Carmustine—malignant glioma	0.00381	0.00381	CcSEcCtD
Cefpodoxime—Constipation—Carmustine—malignant glioma	0.00381	0.00381	CcSEcCtD
Cefpodoxime—Dyspepsia—Temozolomide—malignant glioma	0.00379	0.00379	CcSEcCtD
Cefpodoxime—Decreased appetite—Temozolomide—malignant glioma	0.00375	0.00375	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00372	0.00372	CcSEcCtD
Cefpodoxime—Fatigue—Temozolomide—malignant glioma	0.00372	0.00372	CcSEcCtD
Cefpodoxime—Constipation—Temozolomide—malignant glioma	0.00369	0.00369	CcSEcCtD
Cefpodoxime—Pain—Temozolomide—malignant glioma	0.00369	0.00369	CcSEcCtD
Cefpodoxime—Feeling abnormal—Carmustine—malignant glioma	0.00367	0.00367	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Carmustine—malignant glioma	0.00365	0.00365	CcSEcCtD
Cefpodoxime—Feeling abnormal—Temozolomide—malignant glioma	0.00355	0.00355	CcSEcCtD
Cefpodoxime—Body temperature increased—Carmustine—malignant glioma	0.00353	0.00353	CcSEcCtD
Cefpodoxime—Abdominal pain—Carmustine—malignant glioma	0.00353	0.00353	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Temozolomide—malignant glioma	0.00352	0.00352	CcSEcCtD
Cefpodoxime—Urticaria—Temozolomide—malignant glioma	0.00342	0.00342	CcSEcCtD
Cefpodoxime—Body temperature increased—Temozolomide—malignant glioma	0.00341	0.00341	CcSEcCtD
Cefpodoxime—Abdominal pain—Temozolomide—malignant glioma	0.00341	0.00341	CcSEcCtD
Cefpodoxime—Hypersensitivity—Carmustine—malignant glioma	0.00329	0.00329	CcSEcCtD
Cefpodoxime—Asthenia—Carmustine—malignant glioma	0.0032	0.0032	CcSEcCtD
Cefpodoxime—Hypersensitivity—Temozolomide—malignant glioma	0.00318	0.00318	CcSEcCtD
Cefpodoxime—Asthenia—Temozolomide—malignant glioma	0.00309	0.00309	CcSEcCtD
Cefpodoxime—Diarrhoea—Carmustine—malignant glioma	0.00305	0.00305	CcSEcCtD
Cefpodoxime—Pruritus—Temozolomide—malignant glioma	0.00305	0.00305	CcSEcCtD
Cefpodoxime—Dizziness—Carmustine—malignant glioma	0.00295	0.00295	CcSEcCtD
Cefpodoxime—Diarrhoea—Temozolomide—malignant glioma	0.00295	0.00295	CcSEcCtD
Cefpodoxime—Dizziness—Temozolomide—malignant glioma	0.00285	0.00285	CcSEcCtD
Cefpodoxime—Vomiting—Carmustine—malignant glioma	0.00284	0.00284	CcSEcCtD
Cefpodoxime—Rash—Carmustine—malignant glioma	0.00281	0.00281	CcSEcCtD
Cefpodoxime—Dermatitis—Carmustine—malignant glioma	0.00281	0.00281	CcSEcCtD
Cefpodoxime—Headache—Carmustine—malignant glioma	0.00279	0.00279	CcSEcCtD
Cefpodoxime—Vomiting—Temozolomide—malignant glioma	0.00274	0.00274	CcSEcCtD
Cefpodoxime—Rash—Temozolomide—malignant glioma	0.00272	0.00272	CcSEcCtD
Cefpodoxime—Dermatitis—Temozolomide—malignant glioma	0.00271	0.00271	CcSEcCtD
Cefpodoxime—Headache—Temozolomide—malignant glioma	0.0027	0.0027	CcSEcCtD
Cefpodoxime—Nausea—Carmustine—malignant glioma	0.00265	0.00265	CcSEcCtD
Cefpodoxime—Nausea—Temozolomide—malignant glioma	0.00256	0.00256	CcSEcCtD
